Tumor Archaeology Reveals that Mutations Love Company  by Setlur, Sunita R. & Lee, Charles
Leading Edge
PreviewsTumor Archaeology Reveals that Mutations
Love Company
Sunita R. Setlur1 and Charles Lee1,*
1Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA
*Correspondence: clee@rics.bwh.harvard.edu
DOI 10.1016/j.cell.2012.05.010
Two studies by Nik-Zainal et al. and a study by Roberts et al. now provide new insights into the
life span of human tumors and the mutational processes that shape the cancer genome. The
bulk of a tumor’s life span is shown to involve the development of subclones, many of which harbor
mutations that are clustered in subchromosomal regions and appear to result from catastrophic
mutational events.The classical theory of cancer genome
evolution posits that cancer development
occurs through gradual accumulation of
mutations or traits that increase cell
survival (Armitage and Doll, 1954; Stratton
et al., 2009). However, some aspects of
cancer evolution can occur on a much
shorter timescale. For example, in the
recently reported phenomenon, chromo-
thripsis, individual chromosomes can be
shattered and reassembled in a single
catastrophic event (Stephens et al.,
2011). In this issue of Cell and in a recent
issue of Molecular Cell, Nik-Zainal et al.
(2012a) and Roberts et al. (2012) describe
another single catastrophic mutational
event whereby point mutations accumu-
late rapidly at somatic hypermutation hot-
spots in a critical step of tumorigenesis.
In Nik-Zainal et al. (2012b), the muta-
tional timeline of human cancers is first
unveiled with the application of a newly
developed, read-depth-based algorithm
to identify patterns of mutations in each
of 21 breast cancer genomes. First, the
authors identified clusters of clones by
measuring (1) read depth that was indica-
tive of ploidy and (2) the allele fraction
harboring the mutation (i.e., older muta-
tions represent higher allele fractions).
To formally simulate the clonal popu-
lations and identify the ‘‘most recent
common ancestor,’’ their approach clus-
tered mutations according to the fraction
of reads harboring the mutation and the
frequency of the event in a given clone.
This allowed for enumeration of distinct
clonal populations inherent in the tumor.
Interestingly, for genomes sequenced to
403 mean coverage, the authors foundthat they had a 5% chance of identifying
a clonal mutation present in 25% of the
tumor sample. These findings illustrate
that because of genetic heterogeneity,
comprehensive identification of genetic
variants in tumors by whole-genome
DNA sequencing strategies requires
much greater read depth than traditionally
used for the identification of common
germline/constitutional genetic variants
(e.g., Mills et al., 2011).
Using an algorithm to phase mutations
into haplotype structures, the authors
found that driver mutations occur before
the onset of large-scale chromosomal
instability (Figure 1A). Shortly thereafter,
and relatively early during tumorigenesis,
a common ancestral clone is established
from which subclones can subsequently
be formed either by gradual accumulation
of genetic alterations or as a result of cata-
strophic events including chromothrip-
sis and ‘‘kataegis’’ (Greek for ‘‘shower’’
or ‘‘thunderstorm’’)—a phenomenon now
revealed by Nik-Zainal et al. (2012a) and
Roberts et al. (2012) whereby point
mutations rapidly occur and cluster
over hundreds (‘‘microcluster’’) or millions
(‘‘macrocluster’’) of DNA bases. In Nik-
Zainal et al. (2012a), five distinct kataegis
‘‘mutational signatures’’ were observed,
each presumably generated by a bio-
logically distinct mutational process (Fig-
ure 1B). Mutational signature A involved
primarily C>T mutations at CpG sites
while signature B was characterized
by three kinds of mutations namely C>T
transitions (at predominantly TpCpA and
TpCpT sites), C>G mutations (at predom-
inantly TpCpA and TpCpT sites) and C>ACellmutations (at TpCpA and TpCpT sites).
Signature C is similar to signature A with
respect to C>T substitutions at CpG sites
but also had an elevated frequency of
C>G mutations at CpG sites when
compared with signature A. Signature D
displayed a uniform distribution of the
different mutational classes. Signature E
had C>G mutations at TpCpA, TpCpC,
and TpCpT trinucleotide sites but lacked
the increased amount of C>T mutations
at TpCp sites that are associated with
signature B.
Roberts et al. (2012) also recognized
this hypermutation phenomenon and ex-
perimentally investigated the underlying
mechanism by inducing DNA damage of
two artificially juxtaposed genes in the
yeast Saccharomyces cerevisiae. The
rate of mutations at the clustered regions
was 500-fold higher than at other regions
of the genome. The accumulation ofmuta-
tions at TC(W)/(W)GA sites in a ‘‘strand-
coordinated manner’’ (i.e., the mutations
were clustered on the same parental
DNA strand) was strong evidence for
the occurrence of these mutational
events in a single cell cycle. The authors
further postulated that the clustering of
these point mutations emanated from
the formation of single-stranded DNA
(ssDNA) that resulted from DNA double-
strand break (DSB) repair or alternatively
during formation of replication forks at
the site of damaged DNA. Evidence for
the latter mechanism came from ex-
periments that disrupted genes crucial
for the replication fork complex leading
to replication fork defects as well as
increased localized hypermutation.149, May 25, 2012 ª2012 Elsevier Inc. 959
Figure 1. Mutational Life Span of a Human Tumor
(A) Whole-genome DNA sequencing provides archaeological evidence for the accumulation of point mutations and chromosomal rearrangements over decades
of a tumor’s life span. Driver mutations (such as PIK3CA and TP53mutations or ERBB2, MYC, orCCND1 amplifications—yellow lightening) first appear and often
subsequently lead to genomic instability. A ‘‘common ancestor’’ is then established relatively early during tumorigenesis. This is followed by a long period of tumor
evolution (vertical blue line) where subclones are formed—in many cases, via chromosomal shattering and aberrant refusion events (chromothripsis—orange
lightening) and/or regional accumulation of alkylation-based damage of cytosines and guanines (kataegis—green lightening). These events can occur
concurrently or separately. A later rate-limiting step then occurs that permits one dominant clone to grow expeditiously (vertical red line) to account for more than
50% of a clinically recognizable tumor.
(B) Five distinct signatures (A–E) of kataegis were identified. Kataegis is thought to occur when DNA damages (light green lightening) result in double-strand DNA
breaks that yield single-stranded DNA (ssDNA) or replication forks that expose ssDNA. The ssDNAs can be acted on by APOBEC enzymes with affinity for TC(W)/
(W)GA motifs (purple lightening). Kataegis can deposit mutations within genomic clusters that are hundreds of bases in length (microcluster) or upwards of
millions of bases in length (macrocluster) and can be associated with or independent of chromothripsis.Based on the mutational patterns
observed, both Roberts et al. (2012) and
Nik-Zainal et al. (2012a) speculated that
the point mutational clustering found in
human tumors is mediated by the action
of the APOBEC family of proteins. These
proteins show a preference for ssDNA
and mediate events such as the deami-
nation of cytosines to uracil, which are
then converted into thymine by base
excision repair mechanisms.
Association of the chronological molec-
ular timescale between chromothripsis
and kataegis revealed that the two events
could occur simultaneously at certain
chromosomal regions but are not
universal across the entire genome. In
addition, kataegis was seen to occur
multiple times during tumor evolution
(Figure 1A). The findings from Nik-Zainal
(2012b) also showed that a dominant960 Cell 149, May 25, 2012 ª2012 Elsevier Insubclone emerges from a late rate-limiting
step, carrying multiple mutations that had
accumulated since the ‘‘most recent
common ancestor.’’ The ‘‘most recent
common ancestor’’ bore key driver muta-
tions and appeared to be a relatively long-
lived, quiescent population, which are
also hallmarks of cancer stem cells.
These features, coupled with an ability to
generate new dominant clones, pose
challenges for therapeutic intervention
as resulting subclones are well poised to
rapidly become resistant to new thera-
peutic interventions. Indeed, the pres-
ence of such competing subclones create
a situation whereby each subclone is
capable of gaining dominance quickly,
even when an initial dominant subclone
is eradicated from the tumor (Mullighan
et al., 2008). In addition, generation of
a new dominant clone may be facilitatedc.by therapy-related cellular stress that
could promote further chromothripsis/
kataegis events leading to accelerated
selection (Heng et al., 2010).
With more data accumulating from
whole genome DNA sequencing of
tumors, we now have an unprecedented
opportunity to excavate data that can
subsequently be used to reconstruct the
mutational and evolutionary history of
a cancer’s genome. Although the majority
of mutational events present in the cancer
genome will likely not play a major role in
tumor development, the unearthing of
mutational signatures by using whole-
genome DNA sequencing at high levels
of sensitivity provides new insight into
the processes that shape the cancer
genome, offers opportunities to define
new cancer subtypes, and ultimately
contributes to a more comprehensive
understanding of disease progression.
What were once thought to be merely
random events in cancer evolution are
now being recognized as important
mutational signatures in the biography of
a human tumor.
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LINC complexes are structures embedded within the nuclear envelope that mechanically couple
the nucleus and cytoskeleton. They consist of SUN domain proteins of the inner nuclear membrane
associated with KASH domain proteins in the outer nuclear membrane. Atomic resolution struc-
tures of SUN-KASHpairs nowprovide new insight in to themechanisms of LINC complex assembly.Observations stretching back more than
two decades have suggested that nuclei
and nuclear components are mechani-
cally coupled to the cytoskeleton. In
multicellular organisms, this mechanical
coupling may extend beyond the plasma
membrane to the extracellular matrix and
adjacent cells. More recently, studies on
a variety of human diseases associated
with defects in nuclear envelope (NE)
proteins have revealed that, not only can
the cytoskeleton affect nuclear organiza-
tion, but changes in nuclear architecture
may have a reciprocal affect on cytoskel-
etal function (Burke and Roux, 2009). In
this issue, Sosa et al. (2012) provide an
atomic resolution description of key inter-
actions at the NE that link nuclear and
cytoplasmic components.
The most prominent features of the NE
are inner and outer nuclear membranes
(INM and ONM) separated by a gap,
or perinuclear space (PNS), of about
40–50 nm. The two membranes arespanned by nuclear pore complexes at
annular junctions. The ONM also displays
connections to the endoplasmic reticulum
(ER). In this way, the ER, ONM, and INM
represent separate domains within a
single continuous membrane system,
with the PNS forming an extension of the
ER lumen. Whereas the INM contains a
unique array of membrane proteins, the
composition of the ONM closely resem-
bles that of the ER. Nevertheless, the
ONM is enriched in several integral
membrane proteins that function as
adapters for a variety of cytoskeletal com-
ponents, including motor proteins. In
vertebrate cells, these ONM proteins are
represented, in part, by members of the
Nesprin or Syne family.
The common feature of all known
ONM-specific proteins, including Ne-
sprins, is a C-terminal KASH (Klarsicht,
Anc1, Syne homology) domain of 50–60
amino acid residues (Burke and Roux,
2009). The KASH domain consists of asingle-membrane spanning helix followed
by a sequence of about 30 residues that
extends into the PNS. Localization of
KASH domain proteins to the ONM is
dependent upon interaction with integral
proteins of the INM that belong to the
SUN (Sad1p, Unc84) domain family. In
mammalian cells, there are two widely ex-
pressed SUN domain proteins, Sun1 and
Sun2. The SUN domain itself is a highly
conserved 200 amino acid C-terminal
sequence that resides within the PNS
at the end of a helical ‘‘stalk’’ and can
interact directly with KASH domains of
ONM proteins. In this way, proteins
such as Sun1 and Sun2 function as
transluminal tethers for Nesprin proteins
in the ONM.
The nucleoplasmic domains of SUN
proteins are associated with a variety of
nuclear components, including the
nuclear lamina, an important structural
feature of the NE that is closely associ-
ated with both the INM and underlying149, May 25, 2012 ª2012 Elsevier Inc. 961
